Horibe, R., Hirohashi, Y., Asano, T., Mariya, T., Suzuki, T., Takaya, A., . . . Torigoe, T. (2017). Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy. PLoS One.
Stile di citazione ChicagoHoribe, Ryota, et al. "Brother of the Regulator of the Imprinted Site (BORIS) Variant Subfamily 6 Is a Novel Target of Lung Cancer Stem-like Cell Immunotherapy." PLoS One 2017.
Citazione MLAHoribe, Ryota, et al. "Brother of the Regulator of the Imprinted Site (BORIS) Variant Subfamily 6 Is a Novel Target of Lung Cancer Stem-like Cell Immunotherapy." PLoS One 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.